Introduction
Among the gastrointestinal carcinomas, human pancreatic cancer is well known for its poor prognosis.
Recently, many studies have suggested that expressions of growth factors and oncoproteins might be associated with lymph node metastasis, tumor size, infiltration, histologic grade and prognosis1) . The epidermal growth factor, a polypeptide consisting of 53 amino acids, stimulates proliferation of not only normal epidermal cells but also some carcinoma cells through the epidermal growth factor receptor2, 3). This receptor, a glycoprotein with a molecular weight of The c-erbB-2 gene has the same structure as the HER-2/neu gene9, 10) , whose product is a glycoprotein of 185 kDa existing on cell surfaces. The protein has a sequence homology close to that of the EGFR/c-erbB-1 oncoprotein11) . In breast, gastric and colonic carcinomas, positive staining of the c-erbB-2 oncoprotein has been shown to correlate with poor prognosis12) . Moreover, the erbB-2 mRNA level rises earlier than the EGFR mRNA level13, 14 and lymph node metastasis as well as the patients' mean survival period were also studied.
Materials and Methods

Materials
Thirty-five human pancreatic tissues were examined, of which 25, including 13 regional metastatic lymph nodes were tumorous and 10 were non-tumorous and non-inflammatory. The tissues were obtained through surgery at the First Department of Surgery, Nippon Medical School Hospital, from 1984 to 1989.
Immunohistochemical assay
All of the specimens were fixed in neutralized 10% formalin solution, embedded in paraffin, and cut into 2.0 micrometer sections. The deparaffinized sections were pretreated with 0.3% hydrogen peroxide (11202) /methanol (1: 100 dilution) and with 10% normal goat serum at room temperature.
For EGF staining the sections were incubated with rabbit antiserum to human EGF (Wakunage Pharmaceutical Co., Ltd., Hiroshima, Japan) at a dilution of 1: 10 at 4°C for 24 hours and incubated with anti-rabbit IgG biotinylatd antibody (Vector Laboratories, Inc., Burlingame, CA) at a dilution of 1: 50 at room temperature for 1 hour.
For EGFR staining the sections were incubated with mouse antiserum to human EGFR (Tansformation Research, Inc., Framingham, MA) at a dilution of 1: 10 at 4°C for 48 hours and reacted with anti-mouse IgG biotinylated antibody (Vector Laboratories, Inc.) at a dilution of 1: 10 at 4°C for 24 hours. For c-erbB-2 oncoprotein staining the sections were incubated with antiserum to human c-erbB-2 protein product (Nichirei Co., Ltd., Tokyo, Japan) at a dilution of 1: 50 at 4°C for 24 hours and reacted with anti-mouse IgG biotinylated antibody (Vector Laboratories, Inc.) at a dilution of 1: 100 at room temperature for 1 hour.
(53) •\53•\ Table 1 Histopathological and clinical factors in the general rules for cancer of the pancreas laid down by the Japan Pancreas Society All the slices were then reacted with avidin-biotin-peroxidase complex (ABC) for 1 hour with an ABC kit (Vector Laboratories, Inc.). As positive controls, normal tissue from the human submandibular gland was used for EGF, A431 cells for EGFR, and human breast cancer (tubular adenocarcinoma) tissue for the c-erbB-2 oncoprotein. As negative controls, the sections were incubated with non-immunized rabbit IgG for EGF and with non-immunized mouse IgG for EGFR and the c-erbB-2 protein product instead of each immunized primary antiserum. After treatment with 0.03% diaminobenzidine solution containing 0.01% hydrogen peroxide, the sections were counterstained with methylgreen for light microscopic examination.
The level of immunoreactivity of EGF, EGFR and the c-erbB-2 oncoprotein correlated as follows with the percentage of positively stained cancer cells: more than 50%, +++; 25 to 50%,++; less than 25%, +; 0%, -.
Histopathological and clinical evaluations
All the tissues were stained with hematoxylin and eosin for light microscopic study.
Histological and clinical findings of carcinomas were classified according to the General Rules for
Cancer of the Pancreas laid down by the Japan Pancreas Society19) ( Table 1) .
Statistics
The data obtained in this study were analyzed for statistical significance using the chi-square test with Yates' correction or the Wilcoxon test.
Results
Histopathological findings
The 25 primary lesions were classified as follows: 1 papillary adenocarcinoma, 14 well differentiated tubular adenocarcinomas, 6 moderately differentiated tubular adenocarcinomas, 1 Table  2 Characteristics of the cancer patients poorly differentiated tubular adenocarcinoma, 1 mucinous adenocarcinoma, and 2 undifferentiated carcinomas. Carcinomas whose histological pattern was papillary adenocarcinoma, well or moderately differentiated tubular adenocarcinoma, or mucinous adenocarcinoma were defined here as differentiated types. Carcinomas whose histologic pattern was poorly differentiated tubular adenocarcinoma or undifferentiated carcinoma were defined as undifferentiated types. Adjacent to each cancerous lesion, there were fibrotic changes, atrophy of acini and hyperplasia of ductal epithelium, which are close to the findings of chronic pancreatitis. Thirteen lymph nodes with metastatic carcinomas were also histologically confirmed.
In the 10 non-cancerous and non-inflammatory tissues, neither fibrosis, atrophy of acini, nor hyperplasia of ductal epithelium were found.
2. Immunohistochemical expressions of EGF, EGFR and the c-erbB-2 oncoprotein in pancreatic carcinomas The characteristics of the cancer patients are shown in Table 2 . EGF was stained mainly in the cytoplasm and on the surfaces of cancer cells in 18 of the 25 (72%) cases (Fig. 1) . EGFR was stained mainly on the surfaces and in the cytoplasm of the cells in 9 cases (36%) (Fig. 2) . The c-erbB-2 oncoprotein was seen mainly on the surfaces and in the cytoplasm of the cells in 7 cases (28%) (Fig.  3 ) . As shown in Table 5 , a significant correlation was demonstrated between the invasion into the anterior area (s) and EGF, EGFR and the c-erbB-2 oncoprotein (p<0.01) . As for EGF and EGFR, significant correlations were observed with the invasion into the anterior area (s) and the posterior (57) •\57•\ area (rp) (p<0.005, p<0.05, respectively). A significant correlation was also found between the invasion into the anterior area (s) and EGF positive and EGFR negative staining (p<0.01).
A significant correlation between differentiated and undifferentiated types was observed in the expression of EGF (p<0.01) ( Table 6 ) .
The relationship between primary lesions and metastaic lymph nodes
In each of the 13 cases of primary lesions and metastatic lymph nodes, the expressions of EGF, EGFR and the c-erbB-2 oncoprotein were seen in 10 (77%) , 5(38%) , and 3 (23%) of the primary lesions and in 7 (54%) , 2 (15%) , and 2 (15%) of the lymph nodes respectively. Their positive rates were higher in the primary lesions than in the lymph nodes.
•\ 58•\ Recent papers have emphasized the important interaction between cancer cells and adjacent stroma in cancer cell growth1, 32) . In gastric cancer. EGF and EGFR existed immunohistochemically more frequently in scirrhous types than in non-scirrhous types20, 24) . In vitro, the proliferation of fibroblasts is known to be activated by exogenous EGF33, 34) . In this examination, (1) 9 of 25 carcinomas were both EGF and EGFR positive; (2) expressions of EGF and EGFR were found in fibroblasts and endothelial cells; (3) the cancerous tissues in which EGF and EGFR existed were coincident with the adjacent pancreatic tissues with inflammation in which they existed; and (4) EGF and EGFR were rarely noted in normal pancreatic tissues. The data from this study, as well as the fact that fibrosis is almost always observed in pancreatic cancer, tend to support the view that EGF secreted by cancer cells binds to the EGFR originating in fibroblasts and endothelial cells through a paracrine mechanism1, 17) . EGF and EGFR played an important role in the secretion of exocrine hormones and pancreatic juice in the normal pancreas35, 36) . On the other hand, Chen et al.17) reported that EGF content in normal pancreatic tissue was much lower than in cancerous or inflammatory tissues of the pancreas. Tahara et al.6) demonstrated that the average EGF content in immunohistochemical positive tumors was significantly higher than that in negative ones in advanced gastric carcinomas. In this study, these 3 proteins were only very rarely detected in some acinar cells, ductal cells, fibroblasts and endothelial cells in normal tissues.
This investigation strongly suggests that the expressions of EGF, EGFR and the c-erbB-2 oncoprotein are associated with the existence of tumor invasion. As for invasion into the anterior area, significant correlations were found with EGF, EGFR and the c-erbB-2 oncoprotein, and for invasion into the posterior area, with EGF and EGFR. The difference in thedata from the anterior and posterior areas may depend on the area of the pancreas in which the cancer developed. No significant correlation was found between these positivities and tumor size, but tumors less than 2 cm in size showed no sign of these three products, a result coincident with early cancers of other organs20, 37) . As for comparison of the expressions of EGF, EGFR and the c-erbB-2 oncoprotein in primary lesions and in metastatic lymph nodes and the relationship between these expressions and clinical findings on lymph node involvement, different mechanisms besides EGF, EGFR and the c-erbB-2 oncoprotein might be involved in the lymph node metastasis of human pancreatic carcinoma.
The mean survival period correlated significantly with the coexpressions of EGF, EGFR and the c-erbB-2 oncoprotein. It also correlated significantly with the coexpressions of EGF and EGFR as well as with EGF. These results indicate that these three proteins contribute to the prognosis of patient with pancreatic cancer and the immunohistochemical expressions of these proteins are useful prognostic predictors for patients who have undergone surgery. Sugiyama et al.24) reported the coexpression of EGF and EGFR correlated significantly with •\ 60•\ (60) the depth of cancer invasion of the stomach and stated that the gastric carcinomas with the presence of both EGF and EGFR might have a mechanism of autocrine theory38) . In the present studies, the coexistence of these 2 products correlated significantly with tumor invasion of the pancreas as well as the mean survival period for patients with pancreatic cancer.
In conclusion, the immunohistochemical coexpressions of EGF and EGFR and the c-erbB-2 oncoprotein are strongly related to the existence of the invasion of pancreatic cancer. Furthermore, EGF, EGFR and the c-erbB-2 oncoprotein are important prognostic indicators of human pancreatic carcinoma.
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